ACTRN12615000854538已完成未知
Pilot Study – Use of [68Ga] gallium-labelled Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) for the Characterisation of Metastatic Lesions in Patients with Renal Cell Carcinoma
Dr Simon Wood0 个研究点目标入组 10 人开始时间: 2015年8月17日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Diagnosis
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •1. Patients with renal mass larger than 2cm
- •2. Indeterminant or likely metastatic lesions on staging CT scan
- •3. No known problems with peripheral intravenous or central line access
- •4. Able to undergo study imaging within 6 weeks of diagnosis
- •5. Able to provide informed signed consent
排除标准
- •1. Age under 18 years
- •2. Administered radioisotope within 5 physical half-lives prior to PSMA PET
- •3. Unable to lie flat during or unable to tolerate PET
- •4. Prior history of any other malignancy within last 2 years
- •5. Contraindication to PET scan or 68 Ga PSMA PET ligand
- •6. Claustrophobia not manageable by oral sedatives. i.e. Temazepam.
- •7. Renal impairment or haemodialysis.
研究者
相似试验
进行中（未招募）
1 期
Pilot study for the evaluation of [68Ga]Ga-PentixaFor PET imaging for the identification of unilateral adrenal secretion of ALdosterON in patients with primary aldosteronism.Primary aldosteronism, Primary aldosteronismMedDRA version: 20.1Level: PTClassification code: 10036692Term: Primary hyperaldosteronism Class: 100000004860CTIS2023-505507-22-00Assistance Publique Hopitaux De Paris60
已完成
不适用
Genesis GBM 001 Phase I/II study of 68Ga-PSMA as a tumour targeting agent in relapsed glioblastomaBrain CancerGlioblastomaBrain CancerCancer - BrainGlioblastomaACTRN12618001346268Genesis Care11
进行中（未招募）
不适用
A prospective study of the use of 68Ga-DOTA-TATE PET/CT in patients with neuroendocrine tumors.Patients with neuroendocrine tumors, who are going to be diagnosed/evaluated with 68Ga-DOTA-TATE PET/CT instead of standard OctreoscanMedDRA version: 14.1Level: LLTClassification code 10062476Term: Neuroendocrine tumorSystem Organ Class: 100000004864EUCTR2012-004313-13-SESkåne University Hospital, Dept of Oncology450
招募中
不适用
68Ga-PSMA PET-CT in biochemical relapse following primary treatment of Prostate Carcinoma (PCa)Recurrent Prostate CarcinomaCancer - ProstateACTRN12615000608561Sir Charles Gairdner Hospital40
已完成
不适用
Examination of the efficacy of the high gamma PGA natto on the suppression of postprandial glucose elevation by single-dose test.JPRN-UMIN000030182Course of clinical research and regional innovation donated by the Japan Agriculture Ibaraki Public Welfare Federation Fuculty of Medicine University of Tsukuba20